Annual Drug Patent Expirations for CONSENSI Consensi is a drug marketed by Coeptis and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Coeptis drug CONSENSI appeared first on DrugPate…
This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…
The post Which drugs have the most supplementa…
Which drugs have the most supplementary protection certificates? Read Post »
Using data from DrugPatentWatch Fred Ledley and his research group at the Center for Integration of Science and Industry at Bentley University published a paper investigating the involvement of government…
The post Government as the First Investor in B…
Government as the First Investor in Biopharmaceutical Innovation Read Post »
In a recent Bloomberg Law article DrugPatentWatch data is used to show a decrease in patent litigation. This likely means fewer generic entrants and less opportunities for consumers to enjoy…
The post Bloomberg and Drug PatentWatch: A “Perfect Storm” A…
Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs Read Post »
In a recent Bloomberg Law article DrugPatentWatch data is used to show a decrease in patent litigation. This likely means fewer generic entrants and less opportunities for consumers to enjoy…
The post Bloomberg and Drug PatentWatch: A “Perfect Storm” A…
Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs Read Post »
Annual Drug Patent Expirations for BEVYXXA Bevyxxa is a drug marketed by Portola Pharms Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Portola Pharms drug BEVYXXA appeared first on D…
New patent expiration for Portola Pharms drug BEVYXXA Read Post »
This chart shows the drugs with the most patents in Singapore. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Singa…
Which pharmaceutical drugs have the most drug patents in Singapore? Read Post »
Annual Drug Patent Expirations for WYNZORA Wynzora is a drug marketed by MC2 and is included in one NDA. The generic ingredient in WYNZORA is betamethasone dipropionate; calcipotriene. Additional details…
The post New patent for MC2 drug WYNZORA appear…
Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in one NDA. There are six patents protecting this drug. This drug…
The post New patent for Global Blood drug OXBRYTA appeared first on DrugPat…
Annual Drug Patent Expirations for FENSOLVI+KIT Fensolvi Kit is a drug marketed by Tolmar and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Tolmar drug FENSOLVI KIT appeared first on DrugP…
Get new actionable insights and updates from BiotechBlog
